Adeno-associated virus vector-based gene therapies for pediatric diseases
Gene therapy using adeno-associated virus (AAV) is a rapidly developing technology with widespread treatment potential. AAV2 vectors injected directly into the brain by stereotaxic brain surgery have shown good results in treating aromatic l-amino acid decarboxylase deficiency. Moreover, gene therap...
Saved in:
| Main Authors: | Kazuhiro Muramatsu, Shin-ichi Muramatsu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-02-01
|
| Series: | Pediatrics and Neonatology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1875957222002133 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adeno-Associated Virus Vectors in Retinal Gene Therapy: Challenges, Innovations, and Future Directions
by: Jiayu Huang, et al.
Published: (2025-06-01) -
Adeno-associated virus gene therapy for hemophilia: an update meta-analysis and systematic review
by: Wuxia Yang, et al.
Published: (2025-05-01) -
The Intra-Articular Delivery of a Low-Dose Adeno-Associated Virus-IL-1 Receptor Antagonist Vector Alleviates the Progress of Arthritis in an Osteoarthritis Rat Model
by: Shuang Luo, et al.
Published: (2024-11-01) -
Immune responses to central nervous system directed adeno-associated virus gene therapy: Does direct CNS delivery make a difference?
by: Ashley L. Harkins, et al.
Published: (2024-07-01) -
An adeno-associated virus gene therapy strategy for anti-obesity treatment by nanocarrier-based delivery systems
by: Li Li, et al.
Published: (2025-07-01)